D635

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Type 2 Diabetes MellitusType2 Diabetes Mellitus

Phase 1

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition

Chong Kun Dang PharmaceuticalType 2 Diabetes Mellitus

Start: 2019-01-28End: 2019-02-28Target: 20Updated: 2019-02-21

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults

Chong Kun Dang PharmaceuticalType2 Diabetes Mellitus

Start: 2019-01-14End: 2019-02-22Target: 36Updated: 2019-02-21